English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The serum activities of adenosine deaminase (ADA) and its isozymes (ADA 1 and ADA 2) were measured in 31 patients with myasthenia gravis (MG). As compared with 50 normal controls, in MG the total activity and ADA 1 were significantly high (p &lt; 0.01, respectively), and ADA 2 tended to be high. The total activity and ADA 2 were higher in generalized MG than in ocular MG. ADA 2 was significantly higher in grade IIB patients as compared with grade I patients divided by Osserman's classification (p &lt; 0.05). Patients with bulbar signs showed a significantly high total ADA (p &lt; 0.05) with an increasing tendency for ADA 2. There was a significant elevation of the total activity and ADA 2 in patients with positive anti-acetylcholine-receptor antibody as compared to those of the negative antibody (p &lt; 0.05). It was concluded that total ADA, reflecting the increase of both ADA 1 and ADA 2, is high in MG; and the measurement of ADA 2 is more important because ADA 2 was increased with advancing clinical MG grade.

Isozyme Analysis of the High Serum Adenosine Deaminase Activity in Patients with Myasthenia Gravis.